Tickers

1. Composite Trajectory Verdict

Given VELO's pre-profitability stage, significant operating losses, and explicit going-concern uncertainty, the cash flow statement and balance sheet liquidity position carry the most weight for assessing near-term viability, while the income statement reflects the underlying product-margin dynamics.

Composite Trajectory: Mixed

The cash flow assessment shows clear improvement: operating cash burn narrowed by $5.4 million year-over-year and the cash balance rose from $1.8 million to $39.6 million, driven by $67.8 million in financing inflows (10-K 2025-12-31, Consolidated Statements of Cash Flows). The balance sheet reflects this liquidity gain but also shows rising leverage (long-term debt of $24.7 million vs. zero) and a growing accumulated deficit ($498.1 million vs. $426.8 million) (10-K 2025-12-31, Consolidated Balance Sheets). The income statement is mixed: revenue grew 12.1% to $46.0 million, and the operating loss improved 30% to $54.9 million, but gross margin deteriorated to -16.1% from -5.1% and net loss widened slightly to $71.4 million (10-K 2025-12-31, Consolidated Statements of Operations).

2. Red Flags

• Gross margin collapse despite revenue growth: Gross margin fell to -16.1% in FY2025 from -5.1% in FY2024 while revenue rose 12.1%, driven by higher-cost Sapphire XC/XC 1MZ mix and factory overhead scaling (10-K 2025-12-31, Consolidated Statements of Operations; MD&A Cost of Revenue).
• Going concern doubt reiterated: Management states "substantial doubt exists about the Company's ability to continue as a going concern" and that it "does not have sufficient liquidity to meet its operating needs… for at least 12 months" (10-K 2025-12-31, MD&A Liquidity and Capital Resources; Note 1).
• Accumulated deficit accelerating: Accumulated deficit grew $71.4 million in FY2025 to $498.1 million, nearly matching the FY2024 net loss of $69.7 million (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Operations).
• Net loss widened despite operating improvement: Net loss increased to $71.4 million from $69.7 million due to a $11.4 million loss on warrant cancellation and $1.1 million warrant fair value loss, offsetting a $23.9 million improvement in operating loss (10-K 2025-12-31, Consolidated Statements of Operations).
• Supplier credit constraints: The company is "unable to secure credit terms and volume discounts with our suppliers, causing us to pay a premium, in advance, or source from alternate suppliers at unfavorable terms" (10-K 2025-12-31, MD&A Cost of Revenue).
• Large non-recurring revenue in prior year: FY2024 included $5.0 million of licensing revenue from SpaceX that did not repeat in FY2025 (10-K 2025-12-31, MD&A Revenue).
• Customer concentration: Top three customers represented 33.2% of FY2025 revenue, with all three differing from the prior year's top three (10-K 2025-12-31, MD&A Customer Concentration).
• Inventory reserves remain high: $25.2 million and $27.1 million in inventory reserves recorded in FY2025 and FY2024 respectively (10-K 2025-12-31, Note 6 Inventories).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Revenue increased 12.1% to $45.973 million in FY2025 from $41.003 million in FY2024, driven by a 54.5% rise in 3D Printer and parts revenue to $39.183 million, partially offset by declines in recurring payment (-93.4% to $70K), support services (-35.3% to $6.196 million), and other revenue (-89.5% to $524K) (10-K 2025-12-31, Consolidated Statements of Operations). Gross loss widened to $7.404 million (-16.1% margin) from $2.085 million (-5.1% margin), with cost of revenue rising 23.9% to $53.377 million, including $7.0 million and $7.2 million of excess/obsolete inventory charges in FY2025 and FY2024 respectively (10-K 2025-12-31, Consolidated Statements of Operations; MD&A Cost of Revenue). Total operating expenses fell 38.1% to $47.516 million from $76.709 million, with R&D down 31.2%, S&M down 47.4%, and G&A down 37.8% (10-K 2025-12-31, Consolidated Statements of Operations). Loss from operations improved to $54.920 million from $78.794 million. Net loss, however, increased slightly to $71.362 million from $69.744 million due to an $11.357 million loss on warrant cancellation and a $1.140 million warrant fair value loss (10-K 2025-12-31, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash used in operating activities decreased to $27.327 million in FY2025 from $32.677 million in FY2024, a $5.350 million improvement, despite a higher net loss, reflecting a $24.415 million inventory reduction and $7.960 million increase in accrued expenses (10-K 2025-12-31, Consolidated Statements of Cash Flows). Net cash provided by financing activities surged to $67.833 million from $1.460 million, comprising $28.0 million net proceeds from the December 2025 PIPE, $17.8 million from the August 2025 offering, $15.0 million from secured convertible notes, and $10.0 million from an equipment loan (10-K 2025-12-31, Consolidated Statements of Cash Flows). Cash and cash equivalents (including restricted cash) rose to $39.636 million at year-end 2025 from $1.840 million at year-end 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Investing cash flow turned negative at $2.715 million (property/equipment purchases) from positive $7.767 million in FY2024 (which included $6.7 million of investment maturities/sales) (10-K 2025-12-31, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets grew to $105.348 million from $89.180 million, primarily driven by cash increasing to $39.013 million from $1.212 million (10-K 2025-12-31, Consolidated Balance Sheets). Inventories declined significantly to $27.083 million from $49.953 million, while accounts receivable rose to $6.263 million from $3.723 million (10-K 2025-12-31, Consolidated Balance Sheets; Note 6). Total liabilities increased to $67.192 million from $49.516 million, with the emergence of $24.710 million in long-term debt (equipment loan and convertible notes) versus zero a year prior, and accounts payable falling to $10.301 million from $18.538 million (10-K 2025-12-31, Consolidated Balance Sheets; Note 9). Warrant liabilities dropped to $109K from $2.167 million following warrant exchanges (10-K 2025-12-31, Consolidated Balance Sheets; Note 4). Stockholders' equity declined slightly to $38.156 million from $39.664 million as the accumulated deficit grew to $498.143 million from $426.781 million, despite $69.853 million of equity issuances during the year (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Stockholders' Equity).

6. Data Gaps

• Quarterly revenue, gross margin, operating loss, and cash flow trends for FY2026 (Q1-Q2 2026 10-Qs not fully provided in filings)
• Standalone Q4 2025 results (cannot be derived from annual and nine-month data per period handling rules)
• Quarterly inventory turnover and days sales outstanding trends
• RPS (Rapid Production Solutions) revenue and margin contribution broken out from 3D Printer and parts
• Customer concentration metrics for quarterly periods
• Detailed debt maturity schedule beyond current/non-current split
• Capital expenditure forecasts for 2026 beyond qualitative statements